Table 3. MTB/RIF performance for Mycobacterium tuberculosis detection in per-patient and per-sample analysis.
MTB/RIF per-patient* | MTB/RIF per-sampleŧ | |
Sensitivity | 86.3% (95% CI 74.3–93.2) (44/51) | 97.8% (95% CI 88.4–99.6) (44/45) |
Specificity | 97.5% (95% CI 91.3–99.3) (78/80) | 97.7% (95% CI 91.9–99.4) (84/86) |
Positive predictive value | 95.7% (95% CI 85.5–98.8) (44/46) | 95.7% (95% CI 85.5–98.8) (44/46) |
Negative predictive value | 91.8% (95% CI 84.0–96.0) (78/85) | 98.8% (95% CI 93.6–99.8) (84/85) |
MTB/RIF = Xpert®MTB/RIF.
The per-patient analysis evaluated the performance of MTB/RIF results from the second.
sample only against results from Löwenstein-Jensen (LJ) and Mycobacteria Growth Indicator.
Tube (MGIT), from both first and second sputum samples.
The per-sample analysis was done on the second sputum sample and evaluated the performance.
of MTB/RIF against the results from LJ and MGIT from the second sputum sample.